Clarion, Janea B.

HRN: 27-51-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
AMPICILLIN 250MG (VIAL)
07/26/2025
08/01/2025
IV
160mg
Q12h
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: